| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.015 | 0.6 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.013 | 0.6 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |